Loberg Michael D's Form 4 filing
IGM Biosciences, Inc. (IGMS) · filed Sep 29, 2022
- Accession no.
- 0001209191-22-051559
- Filed
- Sep 29, 2022
- Trade date
- Jul 18-Sep 28, 2022
- Filing delay
- 73 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $139.6K. It was filed 73 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Loberg Michael DCIK 0001233414 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 18, 2022 | Common Stock | GGiftDisposed | −533 | $0.00 | $0 | 0 | Direct | |
| Jul 18, 2022 | Common Stock | GGiftAcquired | +533 | $0.00 | $0 | 22,805 | Indirect | |
| Sep 27, 2022 | Common Stock | PPurchaseAcquired | +507 | $19.99F2 | +$10,134.93 | 23,312 | Indirect | |
| Sep 28, 2022 | Common Stock | PPurchaseAcquired | +6,172 | $20.97F3 | +$129,426.84 | 29,484 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $19.94 to $20.00. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $20.72 to $21.00. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
Referenced by the price of 1 transaction in Table I.